Topvision Eye Specialist Berhad

0332 · KLSE · Healthcare / Medical Care Facilities

0.165MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.165

Open0.165

Day Range0.165 – 0.165

52-Week Range0.1417 – 0.203

Volume67.60K

Market Cap51.12M

P/E (TTM)16.50

Forward P/E12.22

EPS0.01

Dividend Yield12.12%

Beta0.01

50-Day Avg0.1644

200-Day Avg0.1647

About

Topvision Eye Specialist Berhad, together with its subsidiaries, provides ophthalmology healthcare services in Malaysia. The company offers various eye care services for cataract, diabetic retinopathy, retinal detachment, glaucoma, age-related macular degeneration, pterygium, children's eye disorder, and other eye problems, including cornea ulcer, dry eyes, eyelid abscess, foreign body removal, subconjunctival hemorrhage, trauma, and viral conjunctivitis. It also engages in the provision of related medical consultancy services; marketing of eye supplements and health food products; retail sale of food and beverage; and import, export, and distribution of pharmaceuticals, medical devices and goods, cosmetics, and health supplements. The company was founded in 2010 and is headquartered in Shah Alam, Malaysia.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEODr. Kuok Siong Chong
Employees0
HeadquartersNo. 2, Block 2, Jalan Setia Prima (S) U13/S, Shah Alam, Malaysia, 40170, Malaysia
Websitehttps://www.tvesc.com

Leadership

Dr. Kuok Siong ChongCEO & Executive Director · b. 1977
Mr. Hock Nean Liew B.Sc., M.B.A., M.Sc.Founder & Executive Vice Chairman · b. 1956
Ms. Mei Hui TanChief Financial Officer · b. 1984
Ms. Yoke Voon SoongChief Operating Officer · b. 1980
Ms. Youn Kim Wong MAICSACompany Secretary · b. 1981

Financials

Income Statement

Currency: MYR	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	39.45M	42.96M	44.19M	45.81M
Growth (%)	-	+8.88%	+2.87%	+3.67%
Cost of Revenue	19.35M	21.76M	21.58M	22.95M
Gross Profit	20.10M	21.20M	22.61M	22.86M
Gross Margin	50.94%	49.35%	51.16%	49.91%
Operating Expense	10.54M	13.02M	17.96M	17.87M
Operating Income	9.56M	8.18M	4.65M	4.99M
Operating Margin	24.24%	19.05%	10.52%	10.89%
EBITDA	11.14M	12.42M	9.64M	11.59M
EBITDA Margin	28.24%	28.92%	21.83%	25.29%
Net Income	6.11M	4.82M	1.03M	1.99M
Net Income Margin	15.50%	11.23%	2.33%	4.34%
Interest Expense	630.83K	777.34K	978.77K	1.16M
Interest Expense % of Total Revenue	1.60%	1.81%	2.21%	2.54%

Balance Sheet

Currency: MYR	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	47.67M	50.24M	78.88M	75.39M
Total Liabilities	20.71M	20.22M	31.06M	31.58M
Total Equity	26.68M	29.40M	46.97M	42.76M
Cash	6.32M	6.57M	10.09M	10.74M
Net Debt	1.24M	440.80K	2.09M	1.11M

Cash Flow

Currency: MYR	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	10.15M	8.33M	8.49M	7.82M
Capital Expenditure	6.49M	5.00M	12.34M	6.49M
Free Cash Flow	3.66M	3.32M	-3.86M	1.33M
Dividends Paid	2.04M	2.04M	-	6.20M
FCF to OCF	36.03%	39.93%	-45.44%	16.98%
Dividend Paid to FCF	55.94%	61.50%	-	466.66%

Earnings

Report Date	Mar 31, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-
EPS Actual	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.01
Surprise	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap51.12M

Enterprise Value56.02M

Trailing P/E16.50

Forward P/E12.22

Price / Sales1.08

Price / Book1.11

EPS0.01

Book Value0.144

Revenue (TTM)47.40M

Gross Profit (TTM)23.95M

EBITDA10.42M

Profit Margin4.78%

Operating Margin20.23%

Return on Equity5.22%

Return on Assets4.88%

Shares Outstanding309.82M

Shares Float39.03M

Beta0.01

Dividend Yield12.12%

Dividend Rate0.02

Payout Ratio2.70%

Dividends

20261×

0.01Sep 14, 2026

20252×

0.01Dec 10, 20250.01Jun 26, 2025

20231×

0.01Nov 6, 2023

20221×

0.01Jul 26, 2022

20211×

0.01Sep 13, 2021

20201×

0.01Oct 2, 2020

20191×

0.01Oct 2, 2019